Newcomer Pemvidutide

I definitely don't have a degree in pharmacology and I agree that it would be generally useful in conversations like this which are quite complex.

The reason I mentioned the lack of labels is because in addition to binding affinity (strength of attraction between a drug and the receptor it targets) drug efficacy (strength of the reaction a drug causes after binding to a receptor) is also important.

It is possible to have a drug with great affinity but poor efficacy, or great efficacy but poor affinity, and that particular chart tells tells us nothing about the efficacy of those specific drugs.
The gold standard for efficacy is a randomised controlled trial. Not lab reports …
For efficacy you also have side effects to factor in as well …
Some drugs previously made were highly effective until they conducted clinical trials and were later abandoned due to intolerable side effects…
Just food for thought …
 
How much of this is also based on how a person reacts to a particular peptide? Won’t some people have more receptor density in different areas than others?
 
The gold standard for efficacy is a randomised controlled trial. Not lab reports …
For efficacy you also have side effects to factor in as well …

I agree, I just wanted to make sure that when we talk about receptor affinity we're not using it as a proxy for efficacy which is what often happens when people pull out that particular table. It's interesting information but doesn't tell the whole story.
 

Trending content

Forum statistics

Threads
1,710
Messages
26,784
Members
3,290
Latest member
Kujo25
Back
Top